Brief: Medigene Enters Into Exclusive License Agreement With Helmholtz Zentrum Munich

Medigene AG

04/01/2019 06:35

Jan 4 (Reuters) - Medigene AG  MDG1k.DE :
    * HAS ENTERED INTO AN EXCLUSIVE LICENSE AGREEMENT WITH
HELMHOLTZ
ZENTRUM MUNICH (HMGU)
    * LICENSE AGREEMENT FOR A CHIMERIC CO-STIMULATORY RECEPTOR
WHICH
IS A FUSION PROTEIN OF PD-1 AND 4-1BB

Source text for Eikon:  ID:nPexSsLzZa 
Further company coverage:  MDG1k.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))